ABCC4 Antibody

1. Data show that forkhead box protein M1 (FoxM1) enhanced carboplatin resistance in Y-79CR cells through directly up-regulating the transcription of ATP-binding cassette transporter C4 (ABCC4). PMID:30060118
2. MRP4 is mainly responsible for the efflux of lamivudine and entecavir in hepatocyte cultures. PMID:29568871
3. Data suggest that targeting the ATP binding cassette subfamily C member 4 (ABCC4)-membrane palmitoylated protein 1 (MPP1) protein complex can lead to new therapies to improve treatment outcome of acute myeloid leukemia (AML). PMID:29146910
4. A functional polymorphism in the ABCC4 promoter, -1508A>G, may increase extracellular 15-hydroxyeicosatetraenoic acid, sphingosine-1-phosphate, and periostin levels, contributing to airway inflammation in asthmatics. PMID:28659663
5. MRP4 localisation and function are regulated by interactions with SNX27, PSD95, and AP3B1. PMID:27761583
6. MRP4 exports prostaglandin E2 PGE2 and contributes to cell migration/metastasis in basal/triple negative breast cancer cells. PMID:28029661
7. This study provides direct evidence that ganciclovir (GCV) is a substrate of the efflux transporter MRP4 and suggests that the intracellular fate of GCV is significantly influenced by ABCC4 rs11568658 variant in renal transplant recipients receiving GCV PMID:27402191
8. Multidrug resistance protein 4 (MRP4) is a critical protein associated with the antiviral efficacy of nucleos(t)ide analogue (NA)s, and combination therapy of NA and MRP inhibitors could reduce the dosage for long-term NA use. MRP4 expression is an important factor predicting treatment failure in chronic hepatitis B patients and will provide a potential therapeutic target against hepatitis B virus. PMID:26931636
9. All patients with both NUDT15 rs116855232 heterozygous variants and ABCC4 rs3765534 variants suffered from severe leukopenia and required 6-mercaptopurine dose reduction to less than 35 mg/m(2)/da PMID:28883280
10. ABCC4 variant (rs4148500) was significantly associated with hyperuricemia and gout. The gout risk allele was associated with fractional excretion of uric acid in male individuals. PMID:28371506
11. ABCC4 functional SNP in the 3' splice acceptor site of exon 8 (G912T) is associated with unfavorable clinical outcome in children with acute lymphoblastic leukemia PMID:28550450
12. Data suggest that common SNPs in MRP4/ABCC4 (evaluated here via site-directed mutagenesis in recombinant proteins expressed in kidney cell lines) are responsible for variations in transport of methylated arsenic metabolites (major urinary arsenic metabolites in humans), prostaglandin E2, and estradiol-17 beta-glucuronide. PMID:27659809
13. Data indicate that R-flurbiprofen inhibits multidrug resistance-associated protein 4 (MRP4, ABCC4)-mediated prostaglandins (PG) transport. PMID:28042832
14. Analysis of gene-gene interactions with CYP2B6 was particularly useful to reinforce the role of MRP4 and to reveal unknown associations, such as that of DRD3. PMID:27665700
15. The tagSNP ABCC4 rs17268122 appears to be a prognostic factor in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy (nCRT) and surgery, independently of response to nCRT PMID:28011504
16. ABCC4 plays a protective role against cytarabine-mediated insults in leukemic and host myeloid cells. PMID:26842729
17. Results demonstrated the capacity of MRP4 to confer resistance to arsenite (AsIII), as evidenced by cell survival assays when treated with AsIII in the presence or absence of its two differential inhibitors. PMID:26497925
18. Osteoarthritis patient platelets presented a higher expression of MRP4. PMID:26141932
19. Sulfate metabolites R-6-S and R-4'-S were generated from raloxifene in SULT293 expression HEK293 cells. Cellular excretion of the raloxifene sulfates was mainly mediated by BCRP and MRP4. PMID:26611713
20. the specific COX-2 inhibitor meloxicam can increase the intracellular accumulation of doxorubicin and enhance doxorubicin-induced cytotoxicity in A549 cancer cells by reducing the expression of MRP1 and MRP4. PMID:26600514
21. MRP4 overexpression is important to reduce aspirin-selective cell death PMID:26491233
22. Approximately 20% of HIV-infected patients receiving tenofovir showed beta2-microglobulinuria. The C allele at position 4976 of the ABCC4 gene was associated with beta2-microglobulinuria in this population. PMID:26807589
23. MRP4 genotyping may be useful for personalizing the therapeutic dose of 6-mercaptopurine during the acute lymphoblastic leukemia maintenance therapy in Japanese PMID:25403995
24. Genetic variability in ABCC4 may contribute to misoprostol-induced fever in pregnant women PMID:26122863
25. ABCC4 levels were significantly upregulated both in human NK/T-cell lymphoma YTS and SNK-6 cells. ABCC4 overexpression induced chemotherapy resistance to epirubicin and cisplatin in YTS cells, and inhibited apoptosis. PMID:26499190
26. These findings have important clinical implications because they directly highlight an important relationship between ABCC4 transporter function and phosphodiesterases in accounting for the cAMP-directed activity of antithrombotic agents. PMID:26405223
27. Data show the influence of ABCC2 and ABCC4 polymorphisms on tenofovir plasma concentrations in Thai HIV-infected patients PMID:25801567
28. cAMP regulates MRP4 promoter activity PMID:25790437
29. This study aimed to establish SULT1A3 stably transfected HEK293 cells, and to determine the contributions of BCRP and MRP transporters to excretion of chrysin and apigenin sulfates. PMID:26291395
30. The overexpression of MRP4 is related to multidrug resistance in osteosarcoma cells PMID:25879330
31. Multiple drug resistance-associated protein 4 (MRP4), prostaglandin transporter (PGT), and 15-hydroxyprostaglandin dehydrogenase (15-PGDH) as determinants of PGE2 levels in cancer. PMID:25433169
32. These results suggest that eicosapentaenoic acid-derived prostaglandin PGE3, PGF(3alpha), and thromboxane B3 are substrates of ABCC4 and ABCC4 partially contributes to the release of PGE3 and PGF(3alpha). PMID:25275481
33. Similar molecular features between MRP4 and BSEP inhibitors may partially explain why various drugs have affinity for both transporters. PMID:25735837
34. inhibition of ABCC4 gene expression can inhibit the proliferation of multidrug-resistant gastric cancer cells and can enhance gastric cancer cell sensitivity to chemotherapeutic drugs. PMID:25572969
35. Our result indicates that GSTP1rs1695 polymorphism was strongly associated with the response of chemotherapy, whereas ABCC4rs9561778 polymorphism was significantly related with chemotherapy-induced toxicities. PMID:25677905
36. The blockade of ABC transporter MRP4 could help to improve drug effectiveness, reduce tumour growth and prevent recurrence in glioblastoma multiforme. PMID:25028266
37. SNPs most associated with Chemotherapy-induced peripheral neuropathy were in glutathione peroxidase 7 (GPX7) gene. PMID:25586538
38. Influence of PTGS1, PTGFR, and MRP4 genetic variants on intraocular pressure response to latanoprost in Chinese primary open-angle glaucoma patients PMID:25339146
39. MRP4/ABCC4 has a relevant role in tumor growth and apoptosis and in the eradication of leukemic stem cells, providing the basis for a novel promising target in acute myeloid leukemia therapy. PMID:25301721
40. Upregulation of COX-2 in lung cancer promotes overexpression of MRP4 via PGE2-dependent pathway PMID:24909729
41. Hepatically derived enalaprilat is excreted across the hepatic basolateral membrane by MRP4. PMID:24958844
42. Multi-walled carbon nanotubes may act on c-Myc to down-regulate ABCB1/ABCC4 expression. PMID:25461681
43. role of MRP4 in thrombus formation PMID:24836986
44. Genetic variability in key genes in prostaglandin E2 pathway (COX-2, HPGD, ABCC4 and SLCO2A1) and their involvement in colorectal cancer development. PMID:24694755
45. study suggests that ABCC4 serves as a novel predictive biomarker that is responsible for the radioresistance and predicts a poor prognosis for locally advanced rectal carcinoma after neoadjuvant radiotherapy PMID:24454870
46. Knockdown of ABCC4 blocked the cell cycle progression in MGC80-3 gastric cancer cells. PMID:24606721
47. ABCC4 activates oncogenic pathways in esophageal squamous cell carcinoma and facilitates cancer cell development and progression. PMID:24510239
48. Human MRP4 could be a major player in the elimination of arsenic. PMID:24870404
49. NHERF3 is a key regulator of organic transport in the kidney, particularly MRP4-mediated clearance of drug molecules. PMID:24436471
50. These results suggest that in epithelial ovarian cancer, ABCC1/MRP1 may be a marker for aggressiveness because its expression was associated with tumor grade and support that ABCC4/MRP4 may play an unfavourable role in disease outcome. PMID:24024181

Show More

Hide All

HGNC: 55

UNIGENE: Hs.508423

KEGG: hsa:10257

STRING: 9606.ENSP00000366084

OMIM: 605250